- Home
- Publications
- Publication Search
- Publication Details
Title
The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-02-07
DOI
10.3389/fcell.2020.00055
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathway
- (2019) Qing-Feng Xiang et al. Artificial Cells Nanomedicine and Biotechnology
- Targeting slug-mediated non-canonical activation of c-Met to overcome chemo-resistance in metastatic ovarian cancer cells
- (2019) Linlin Chang et al. Acta Pharmaceutica Sinica B
- Axin1 deletion induced hepatocarcinogenesis requires intact β-Catenin but not Notch cascade in mice
- (2019) Yu Qiao et al. HEPATOLOGY
- MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1
- (2019) Hui Li et al. GASTROENTEROLOGY
- The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance
- (2019) Xing Huang et al. Autophagy
- M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma
- (2019) Ningning Dong et al. BRITISH JOURNAL OF CANCER
- Long noncoding RNA NEAT1 suppresses sorafenib sensitivity of hepatocellular carcinoma cells via regulating miR‐335–c‐Met
- (2019) Shuwei Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor
- (2019) Orlando Musso et al. GUT
- ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib
- (2019) Giorgia Marisi et al. Cancers
- Long noncoding RNA HULC promotes hepatocellular carcinoma progression
- (2019) Hongwei Zhang et al. Aging-US
- Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis
- (2019) Zhigang Ren et al. Small
- Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A
- (2018) Xiaofeng Xue et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells
- (2018) Yue Ma et al. BIOMEDICINE & PHARMACOTHERAPY
- Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma
- (2018) Mohamed Bouattour et al. HEPATOLOGY
- β-catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic β-catenin and MET
- (2018) Yan Liang et al. HEPATOLOGY
- LncRNA FLVCR1-AS1 acts as miR-513c sponge to modulate cancer cell proliferation, migration, and invasion in hepatocellular carcinoma
- (2018) Kunsong Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET
- (2018) Jacey J. Liu et al. JOURNAL OF HEPATOLOGY
- Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
- (2018) Yazhuo Zhang et al. Molecular Cancer
- Cinobufacini inhibits epithelial-mesenchymal transition of human hepatocellular carcinoma cells through c-Met/ERK signaling pathway
- (2018) Fanghua Qi et al. BioScience Trends
- Prognostic significance of c-Met, β-catenin and FAK in patients with hepatocellular carcinoma following surgery
- (2018) Xue‑Yi Gong et al. Oncology Letters
- LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma
- (2018) Shaoying Yan et al. GENE
- Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
- (2018) Javier A García-Vilas et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Regorafenib reverses HGF-induced sorafenib resistance by inhibiting epithelial-mesenchymal transition in hepatocellular carcinoma
- (2018) Weibo Chen et al. FEBS Open Bio
- MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto-oncogene and cyclin-dependent kinase 6 in mice
- (2017) Heng Wu et al. HEPATOLOGY
- MiRNA expression profiles reveal the involvement of miR-26a, miR-548l and miR-34a in hepatocellular carcinoma progression through regulation of ST3GAL5
- (2017) Hongjiao Cai et al. LABORATORY INVESTIGATION
- Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells
- (2017) Peng Han et al. Molecular Oncology
- Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges
- (2017) Conor A. Bradley et al. Nature Reviews Clinical Oncology
- Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway
- (2017) Feng Gao et al. ONCOLOGY REPORTS
- Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1
- (2017) Yirui Gui et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Correlations of microvascular blood flow of contrast-enhanced ultrasound and HGF/c-Met signaling pathway with clinicopathological features and prognosis of patients with hepatocellular carcinoma
- (2017) Peng-Hui Zhuang et al. OncoTargets and Therapy
- Deguelin suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-c-Met pathway
- (2017) Ming Li et al. Oncotarget
- Norcantharidin alone or in combination with crizotinib induces autophagic cell death in hepatocellular carcinoma by repressing c-Met-mTOR signaling
- (2017) Chao-Yue Sun et al. Oncotarget
- Diagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosis
- (2017) Adriana Unić et al. ANNALS OF CLINICAL BIOCHEMISTRY
- The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches
- (2017) Chi-Tan Hu et al. Cancers
- Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma
- (2016) Jine Yang et al. CANCER LETTERS
- Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells
- (2016) Zeynep Firtina Karagonlar et al. CANCER SCIENCE
- Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53
- (2016) Wen-Ting Liu et al. CELL CYCLE
- A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
- (2016) Thomas C.C. Yau et al. CLINICAL CANCER RESEARCH
- Targeting Signalling Pathways in Hepatocellular carcinoma
- (2016) Kaja Blagotinšek et al. CURRENT PHARMACEUTICAL DESIGN
- Trends in the development of MET inhibitors for hepatocellular carcinoma
- (2016) Hitomi S Okuma et al. Future Oncology
- Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant β-catenin
- (2016) Junyan Tao et al. HEPATOLOGY
- An infernal cross-talk between oncogenic β-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling
- (2016) Rosa M. Pascale et al. HEPATOLOGY
- Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma
- (2016) Hsin-An Chen et al. HEPATOLOGY
- Madecassoside suppresses proliferation and invasiveness of HGF-induced human hepatocellular carcinoma cells via PKC-cMET-ERK1/2-COX-2-PGE 2 pathway
- (2016) Zexin Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Preclinical Evaluation of AMG 337, a Highly Selective Small Molecule MET Inhibitor, in Hepatocellular Carcinoma
- (2016) Zhiqiang Du et al. MOLECULAR CANCER THERAPEUTICS
- miR-101 Inhibiting Cell Proliferation, Migration and Invasion in Hepatocellular Carcinoma through Downregulating Girdin
- (2016) MOLECULES AND CELLS
- Peritumoral stromal neutrophils are essential for c-Met-elicited metastasis in human hepatocellular carcinoma
- (2016) Min He et al. OncoImmunology
- Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma
- (2015) Y.-K. Kang et al. ANNALS OF ONCOLOGY
- PKCε-mediated c-Met endosomal processing directs fluctuant c-Met-JNK-paxillin signaling for tumor progression of HepG2
- (2015) Chi-Tan Hu et al. CELLULAR SIGNALLING
- Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma
- (2015) Zeynep F. Karagonlar et al. DRUG DEVELOPMENT RESEARCH
- Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity
- (2015) J.-C. Jo et al. MOLECULAR CANCER THERAPEUTICS
- Erratum: Advances in targeted therapies for hepatocellular carcinoma in the genomic era
- (2015) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma
- (2015) Y Gui et al. ONCOGENE
- The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma
- (2015) Steven N. Steinway et al. PLoS One
- Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?
- (2015) Yu-Yun Shao WORLD JOURNAL OF GASTROENTEROLOGY
- Gα12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction
- (2015) Yoon Mee Yang et al. Oncotarget
- Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression
- (2015) Jia-Ru Wu et al. Oncotarget
- MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A
- (2015) Katsuya Ohta et al. Oncotarget
- miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met
- (2014) Peyda Korhan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Des-γ-Carboxy Prothrombin (DCP) as a Potential Autologous Growth Factor for the Development of Hepatocellular Carcinoma
- (2014) Yu-Sheng Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
- (2014) Masatoshi Kudo et al. HEPATOLOGY
- Four individually druggable MET hotspots mediate HGF-driven tumor progression
- (2014) Cristina Basilico et al. JOURNAL OF CLINICAL INVESTIGATION
- Tivantinib (ARQ 197) Exhibits Antitumor Activity by Directly Interacting with Tubulin and Overcomes ABC Transporter-Mediated Drug Resistance
- (2014) A. Aoyama et al. MOLECULAR CANCER THERAPEUTICS
- The Met receptor tyrosine kinase: A key player in oncogenesis and drug resistance
- (2014) Christiane R. Maroun et al. PHARMACOLOGY & THERAPEUTICS
- The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer Models
- (2014) Friedhelm Bladt et al. Cancers
- GSK3 Alpha and Beta Are New Functionally Relevant Targets of Tivantinib in Lung Cancer Cells
- (2013) Lily L. Remsing Rix et al. ACS Chemical Biology
- The emerging role of MET/HGF inhibitors in oncology
- (2013) Giorgio V. Scagliotti et al. CANCER TREATMENT REVIEWS
- Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
- (2013) L. Goyal et al. CLINICAL CANCER RESEARCH
- Targeting MET: why, where and how?
- (2013) Elena Ghiso et al. CURRENT OPINION IN PHARMACOLOGY
- MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway
- (2013) Xin Yang et al. HEPATOLOGY
- HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma
- (2013) Shugaku Takeda et al. JOURNAL OF CLINICAL INVESTIGATION
- Linking MLL and the HGF-MET signaling pathway in liver cancer
- (2013) Jens U. Marquardt et al. JOURNAL OF CLINICAL INVESTIGATION
- Met as a therapeutic target in HCC: Facts and hopes
- (2013) Silvia Giordano et al. JOURNAL OF HEPATOLOGY
- Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
- (2013) Jessica Dyson et al. JOURNAL OF HEPATOLOGY
- Lessons from (S)-6-(1-(6-(1-Methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)ethyl)quinoline (PF-04254644), an Inhibitor of Receptor Tyrosine Kinase c-Met with High Protein Kinase Selectivity but Broad Phosphodiesterase Family Inhibition Leading to Myocardial Degeneration in Rats
- (2013) J. Jean Cui et al. JOURNAL OF MEDICINAL CHEMISTRY
- MicroRNA-148a suppresses the epithelial–mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling
- (2013) J-P Zhang et al. ONCOGENE
- Cancer-Associated Fibroblasts from Hepatocellular Carcinoma Promote Malignant Cell Proliferation by HGF Secretion
- (2013) Chang-Chang Jia et al. PLoS One
- Underexpression of miR-34a in Hepatocellular Carcinoma and Its Contribution towards Enhancement of Proliferating Inhibitory Effects of Agents Targeting c-MET
- (2013) Yiwu Dang et al. PLoS One
- MET: A Critical Player in Tumorigenesis and Therapeutic Target
- (2013) C. R. Graveel et al. Cold Spring Harbor Perspectives in Biology
- Cell-Autonomous and Non-Cell-Autonomous Mechanisms of HGF/MET-Driven Resistance to Targeted Therapies: From Basic Research to a Clinical Perspective
- (2013) S. Corso et al. Cancer Discovery
- Seminars in clinical pharmacology: an introduction to MET inhibitors for the medical oncologist
- (2012) A. Fasolo et al. ANNALS OF ONCOLOGY
- Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells
- (2012) Reena Buurman et al. GASTROENTEROLOGY
- Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis
- (2012) Giray Bozkaya et al. Molecular Cancer
- Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia
- (2012) Alex Kentsis et al. NATURE MEDICINE
- miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway
- (2011) Sheng Tan et al. FEBS LETTERS
- c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma
- (2011) Hanning You et al. HEPATOLOGY
- SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes
- (2011) Yirui Gui et al. JOURNAL OF HEPATOLOGY
- Molecular mechanism and physiological functions of clathrin-mediated endocytosis
- (2011) Harvey T. McMahon et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeting c-Met as a promising strategy for the treatment of hepatocellular carcinoma
- (2011) Jianjun Gao et al. PHARMACOLOGICAL RESEARCH
- miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines
- (2010) Jon C. Henry et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion
- (2010) Wei Ding et al. HEPATOLOGY
- ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
- (2010) N. Munshi et al. MOLECULAR CANCER THERAPEUTICS
- The role of signaling pathways in the development and treatment of hepatocellular carcinoma
- (2010) S Whittaker et al. ONCOGENE
- Down-Regulation of c-Met Expression Inhibits Human HCC Cells Growth and Invasion by RNA Interference
- (2009) Bin Xie et al. JOURNAL OF SURGICAL RESEARCH
- Endocytosis and signalling: intertwining molecular networks
- (2009) Alexander Sorkin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Molecular cancer therapy: Can our expectation be MET?
- (2008) Cristina Migliore et al. EUROPEAN JOURNAL OF CANCER
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma
- (2008) Ai-Wu Ke et al. HEPATOLOGY
- MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
- (2008) Yannick Ladeiro et al. HEPATOLOGY
- Hepatocarcinogenesis in mice with a conditional knockout of the hepatocyte growth factor receptor c-Met
- (2008) Philip Marx-Stoelting et al. INTERNATIONAL JOURNAL OF CANCER
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4
- (2008) Kunio Matsumoto et al. PROTEOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started